Kamada

KMDANasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$504.388 M

$8.74 -1.24%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

57,686,056

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#205Capricor TherapeuticsCAPR$517.4M
#206Contineum TherapeuticsCTNM$509.8M
#207KamadaKMDA$504.4M
#208Puma BiotechnologyPBYI$495.0M
#209Turn TherapeuticsTTRX$456.9M

What if Kamada were worth as much as…

Open the what-if tool →

Gold $30.3T

$524,586.62

Per share 60,021× higher

Bitcoin $1.72T

$29,800.63

Per share 3,410× higher

Nvidia $5.48T

$94,954.58

Per share 10,864× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Kamada are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.